Chemokines and squamous cancer of the head and neck: targets for therapeutic intervention? (Q36752040)

16 August 2017

1 reference

title

Chemokines and squamous cancer of the head and neck: targets for therapeutic intervention? (English)

1 reference

16 August 2017

0 references

W Andrew Yeudall

1

1 reference

16 August 2017

Hiroshi Miyazaki

series ordinal

2

1 reference

16 August 2017

publication date

1 March 2007

1 reference

Expert Review of Anticancer Therapy

16 August 2017

published in

1 reference

16 August 2017

volume

7

1 reference

16 August 2017

issue

3

1 reference

16 August 2017

page(s)

351-360

1 reference

Global cancer statistics, 2002

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.351

Inflammation and cancer: back to Virchow?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.351

Chemokines: a new classification system and their role in immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.351

Chemokine/chemokine receptor nomenclature

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.351

Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.351

The biology of chemokines and their receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.351

Chemokines and the tissue-specific migration of lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.351

Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.351

Signal transduction by the chemokine receptor CXCR3: activation of Ras/ERK, Src, and phosphatidylinositol 3-kinase/Akt controls cell migration and proliferation in human vascular pericytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.351

Chemokine-cytokine cross-talk. The ELR+ CXC chemokine LIX (CXCL5) amplifies a proinflammatory cytokine response via a phosphatidylinositol 3-kinase-NF-kappa B pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.351

CXCL16 signals via Gi, phosphatidylinositol 3-kinase, Akt, I kappa B kinase, and nuclear factor-kappa B and induces cell-cell adhesion and aortic smooth muscle cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.351

PAK1 kinase is required for CXCL1-induced chemotaxis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.351

The Galpha13-Rho signaling axis is required for SDF-1-induced migration through CXCR4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.351

The CXCR1 tail mediates beta1 integrin-dependent cell migration via MAP kinase signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.351

Chemokine-protease interactions in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.351

The chemokine GRO-alpha (CXCL1) confers increased tumorigenicity to glioma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.351

The chemokine receptor CXCR2 controls positioning of oligodendrocyte precursors in developing spinal cord by arresting their migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.351

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.351

Production of chemokine CXCL1/KC by okadaic acid through the nuclear factor-kappaB pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.351

A novel NF-kappa B-inducing kinase-MAPK signaling pathway up-regulates NF-kappa B activity in melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.351

Differential regulation of CXC ligand 1 transcription in melanoma cell lines by poly(ADP-ribose) polymerase-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.351

Involvement of chemokine receptors in breast cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.351

The significance of cancer cell expression of the chemokine receptor CXCR4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.351

CXCL12-CXCR4 interactions modulate prostate cancer cell migration, metalloproteinase expression and invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.351

The chemokine stromal cell derived factor-1 (CXCL12) promotes glioma invasiveness through MT2-matrix metalloproteinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.351

Immune Evasion by Murine Melanoma Mediated through CC Chemokine Receptor-10

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.351

p53 Attenuates cancer cell migration and invasion through repression of SDF-1/CXCL12 expression in stromal fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.351

p53: at the crossroads of molecular carcinogenesis and risk assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.351

Stromal fibroblasts in cancer: a novel tumor-promoting cell type

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.351

Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.351

Molecular genetic alterations in the laser‐capture–microdissected stroma adjacent to bladder carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.351

Inhibition of Src family kinases blocks epidermal growth factor (EGF)-induced activation of Akt, phosphorylation of c-Cbl, and ubiquitination of the EGF receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.351

Acquisition of anoikis resistance is a critical step in the progression of oral tongue cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.351

Chemokine receptor CCR7 induces intracellular signaling that inhibits apoptosis of mature dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.351

Angiogenesis in life, disease and medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.351

Interleukin-8 as a macrophage-derived mediator of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.351

Macrophages regulate the angiogenic switch in a mouse model of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.351

Akt plays a central role in sarcomagenesis induced by Kaposi's sarcoma herpesvirus-encoded G protein-coupled receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.351

CXC chemokines in angiogenesis of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.351

Cell cycle-dependent expression of CXC chemokine receptor 3 by endothelial cells mediates angiostatic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.351

An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.351

Growth-regulated oncogene-1 expression is associated with angiogenesis and lymph node metastasis in human oral cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.351

Growth factor-sensitive molecular targets identified in primary and metastatic head and neck squamous cell carcinoma using microarray analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.351

Down-regulation of CXCL5 inhibits squamous carcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.351

Investigation of CXCR4 in squamous cell carcinoma of the tongue

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.351

Expression pattern of chemokine receptor 6 (CCR6) and CCR7 in squamous cell carcinoma of the head and neck identifies a novel metastatic phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.351

Chemokine receptor 7 activates phosphoinositide-3 kinase-mediated invasive and prosurvival pathways in head and neck cancer cells independent of EGFR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.351

Targeting the immune system: novel therapeutic approaches in squamous cell carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.351

Immunobiology of head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.351

Cancer regression in patients after transfer of genetically engineered lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.351

CCL19 reduces tumour burden in a model of advanced lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.351

Blockade of the chemokine receptor CXCR2 inhibits pancreatic cancer cell-induced angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.351

HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.351

The bicyclam AMD3100 story

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.351

A small-molecule inhibitor directed against the chemokine receptor CXCR4 prevents its use as an HIV-1 coreceptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.351

A duodenally absorbable CXC chemokine receptor 4 antagonist, KRH-1636, exhibits a potent and selective anti-HIV-1 activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.351

Inhibition of CXCR4 with the novel RCP168 peptide overcomes stroma-mediated chemoresistance in chronic and acute leukemias.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.351

A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.351

Enhanced targeting and killing of tumor cells expressing the CXC chemokine receptor 4 by transducible anticancer peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.351

Inhibition of NF-kappaB activity enhances TRAIL mediated apoptosis in breast cancer cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.351

NF-kappaB in cancer: from innocent bystander to major culprit

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.351

NF-kappaB: linking inflammation and immunity to cancer development and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.351

NF-kB in development and progression of human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.351

Biological effects of curcumin and its role in cancer chemoprevention and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.351

Proteasome inhibition leads to NF-kappaB-independent IL-8 transactivation in human endothelial cells through induction of AP-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.351

PPAR-gamma activation inhibits angiogenesis by blocking ELR+CXC chemokine production in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.351

Hemopoietic Stem Cell Inhibitor (SCI/MIP-1∝) Also Inhibits Clonogenic Epidermal Keratinocyte Proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.351

Frequent somatic mutations in PTEN and TP53 are mutually exclusive in the stroma of breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.351

Chemokine stimulation of human peripheral blood T lymphocytes induces rapid dephosphorylation of ERM proteins, which facilitates loss of microvilli and polarization

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.351

21 January 2018

Identifiers

DOI

10.1586/14737140.7.3.351

1 reference

16 August 2017

1 reference